2008
DOI: 10.1158/0008-5472.can-07-6763
|View full text |Cite
|
Sign up to set email alerts
|

Phosphatidylcholine-Specific Phospholipase C Activation in Epithelial Ovarian Cancer Cells

Abstract: Elucidation of the mechanisms responsible for aberrant phosphatidylcholine (PC) metabolism in cancer cells may allow identification of novel biomarkers of tumor progression and design of new targeted anticancer therapies. We recently reported up-regulation of PC-specific phospholipases in epithelial ovarian cancer cells (EOC) compared with nontumoral (normal or immortalized) counterparts (EONT). In the present study, we focused, in the same cell systems, on levels, subcellular localization, and activity of PC-… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
95
0

Year Published

2009
2009
2014
2014

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 87 publications
(102 citation statements)
references
References 47 publications
7
95
0
Order By: Relevance
“…Those studies reported that AGTR2 could block AGTR1-mediated signal transduction by negative cross-talk via the phosphorylation of PLC β 3 in the cytoplasm, rather than by the direct interaction on the cell surface. Activation of PLC β 3 mediates signal transduction for tumor progression in various cancer cell types including epithelial ovarian carcinoma [29,30]. Consistent with those findings, we observed that Ang II increased the expression of phosphorylated PLC β 3 and either losartan or CGP42112A blocked those increases.…”
Section: Discussionsupporting
confidence: 90%
“…Those studies reported that AGTR2 could block AGTR1-mediated signal transduction by negative cross-talk via the phosphorylation of PLC β 3 in the cytoplasm, rather than by the direct interaction on the cell surface. Activation of PLC β 3 mediates signal transduction for tumor progression in various cancer cell types including epithelial ovarian carcinoma [29,30]. Consistent with those findings, we observed that Ang II increased the expression of phosphorylated PLC β 3 and either losartan or CGP42112A blocked those increases.…”
Section: Discussionsupporting
confidence: 90%
“…20 Blots were incubated with rabbit anti-OVA and anti-NOX-2 Abs (Abcam). Actin was used as quantitative loading control (mouse anti-actin was from Sigma-Aldrich).…”
Section: Western Blot Analysismentioning
confidence: 99%
“…Enzymes such as sphingosine kinases, sphingomyelinases, ceramidases, lipid kinases and phosphatases, and phospholipases are altered in cancer tissues [12,16,19,34,36,37,75,76]. These proteins by themselves might not represent ideal biomarkers, unless they are liberated into the blood stream or urine.…”
Section: Functional Validation Of Surrogate Biomarkersmentioning
confidence: 99%